Larvol Delta - Rollover-Study-to-Assess-Safety-of-Lixivaptan-in-Participants-With-ADPKD-Who-Completed-Study-PAADPKD303

Lixar (lixivaptan) - Centessa

http://clinicaltrials.gov/ct2/show/NCT05208866

Jun 9, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next